Walkers supports Akin in advising Pharmakon in its $646 million secured financing to fund Collegium's acquisition of Ironshore Therapeutics.
Pharmakon Advisors, LP and its affiliated funds provided Collegium Pharmaceutical with a $646 million secured financing to be used to help fund Collegium's acquisition of Ironshore Therapeutics Inc., a privately held, pharmaceutical company.
Our Finance team acted as Cayman Islands counsel to Pharmakon Advisors, LP. The team was led by partner Justin Hart with assistance from associate Samuel Buchan, based in Cayman Islands.